Complications from robotic prostatectomy no better than conventional surgery ‹ Journal of Clinical Oncology Problems with continence and sexual function are common following both robot-assisted laparoscopic radical prostatectomy (RALRP) and open retropubic radical prostatec-tomy (ORRP), [more]
Once every seven years an opportunity arises to influence the shape of the European science research effort. This editorial takes a look at what is at stake in the current discussions around the European Research [more]
Decisions on how best to deliver high-quality care should be left to the clinicians who run the services. John Crown, who has long played a leading role in both the clinic and research is one [more]
Patient advocates and professionals alike believe these groundbreaking guidelines will raise standards of care, give much-needed structure to clinical research and improve awareness about a group of patients whose needs have been neglected for too [more]
Massimo Conio looks at the evidence for two alternatives to oesophagectomies–endoscopic mucosal resection and radiofrequency ablation–and discusses which patients should be eligible and where the treatments should be carried out. We can safely and effectively [more]
Being alert to early signs of cancer gives the best chance of survival. Silja Paavle, reporter on the Estonian daily Öhtuleht, helped to pass on this message with this article which won her a Best [more]
From a disastrous chemical explosion in Toulouse arises an innovative hospital with unique links to research and industry. Jean-Pierre Armand has seen his dream cancer centre at the Toulouse ‘oncopole’ through to completion. “If only [more]
Information on how the performance of individual clinicians, teams and hospitals compares with the best is key to driving up standards in cancer care. ECCO is designing and implementing an audit framework named EURECCA to [more]
THE ECOG E4201 study adds another piece of information to a growing body of evidence pointing strongly to the importance of local control and the role of radiotherapy in unresectable pancreatic cancer. Based on this [more]
Screening for prostate cancer using PSA is a careful balance of benefits and harms. But current US practice involves testing older men who have little to gain and aggressively treating low-risk cancers. Debates about whether [more]
The prospect is too exciting to dismiss: a single, inexpensive pill that, taken regularly, can reduce the risk of developing or dying from several types of cancer. The prospect is too exciting to dismiss: a [more]
According to Kaasa, head of the Cancer Clinic at Trondheim University Hospital, patients are falling through gaps in care provision because palliative care is seen as an add-on rather than integral to care plans. The [more]